Accessibility Menu
Zhengye Biotechnology logo

Zhengye Biotechnology(NASDAQ) ZYBT

Market Cap$38.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)-74%
5 YearN/A
1 Year-78%
1 Month+98%
$2.38
+85.94%
+1.10Today
After hours$2.33-$0.05 (-2.10%)
Zhengye Biotechnology last closing stock price
MetricPriceDate
Last closeUSD 1.282026-08-04
Zhengye Biotechnology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.76%USD 1.332026-07-28
1 month+98.08%USD 0.652026-07-02
3 month+29.95%USD 0.992026-05-06
Year to date+11.3%USD 1.152025-12-31
1 year-77.78%USD 5.762025-08-04
Since inception-73.66%USD 4.862025-01-07

Zhengye Biotechnology Financials at a Glance

Market Cap

$38.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

-$0.21

P/E Ratio

-6.23

Dividend

$0.00

Beta (Volatility)

1.16 (Average)

Price

$2.38

Volume

67,968,087.214

Open

$1.26

Previous Close

$1.28

Daily Range

$1.26 - $4.29

52-Week Range

$0.62 - $13.08

Estimated Earnings Date

Jul 28, 2026

ZYBT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zhengye Biotechnology

Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily serves the Chinese agricultural sector with vaccines for various farm animals and also exports to international markets.

Products and Services
  • Vaccines for swine, bovines, goats, ovines, and poultry
  • Inoculations for canines
  • Export of products to markets including Vietnam, Pakistan, and Egypt
Growth Outlook
  • Expansion into international markets is underway, enhancing revenue potential
  • Increasing demand for animal health products in China supports growth
  • Investment in R&D aims to innovate and diversify product offerings
Financial Highlights
  • Recent quarterly revenue of 53,035,920 CNY shows significant growth
  • Trailing twelve months (TTM) revenue of 27,017,000 CNY indicates upward trend
  • Cash and cash equivalents at 50,332,000 CNY provide liquidity for operations
Zhengye Biotechnology Holding Limited operates in the healthcare sector, focusing on animal health. The company has established a strong presence in the Chinese market and is actively pursuing international opportunities. Recent financial performance indicates a positive trajectory, with notable revenue growth in the latest quarter. The company's commitment to research and development positions it well for future expansion and innovation in the animal health industry. With a solid cash position, Zhengye is poised to capitalize on emerging market trends and demands.
AI Generated • Jul 30, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

269

CEO

Aiden Han; Song Lin Song

Website

www.jlzybio.com

Headquarters

Jilin, JI 132101, CN

ZYBT Financials

Key Financial Metrics (TTM)

Gross Margin

8.30%

Operating Margin

-77.04%

Net Income Margin

-89.05%

Return on Equity

-26.78%

Return on Capital

-21.01%

Return on Assets

-16.33%

Earnings Yield

-16.05%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$38.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

29.73M

Volume

67.97M

Avg. Volume

3.81M

Financials (TTM)

Gross Profit

CN¥6.64M

Operating Income

-CN¥61.67M

EBITDA

-CN¥41.40M

Operating Cash Flow

CN¥40.20M

Capital Expenditure

-CN¥1.12M

Free Cash Flow

CN¥39.08M

Cash & ST Invst.

CN¥51.89M

Total Debt

CN¥75.08M

Zhengye Biotechnology Performance Analysis

Zhengye Biotechnology annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 38,651,62716.4%
20232023-12-31CNY 29,872,992-22.7%
20242024-12-31CNY 25,894,223-13.3%
20252025-12-31CNY 16,187,360-37.5%
Zhengye Biotechnology sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31N/A
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-3196.3%
Zhengye Biotechnology annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY 0.1514.8%
20232023-12-31CNY 0.09-36.0%
20242024-12-31CNY 0.03-64.6%
20252025-12-31CNY -0.21N/A
Zhengye Biotechnology sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31N/A
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31-92.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CN¥53.04M

N/A

Gross Profit

CN¥4.40M

N/A

Gross Margin

8.30%

N/A

Market Cap

$38.05MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$141.44K

N/A

Employees

269

N/A

Net Income

-CN¥47.23M

N/A

EBITDA

-CN¥27.41M

N/A

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CN¥51.89M

+509.3%

Total Debt

CN¥75.08M

-14.1%

Accounts Receivable

CN¥18.49M

-79.8%

Inventory

CN¥39.17M

-39.9%

Long Term Debt

CN¥9.18M

N/A

Short Term Debt

CN¥65.91M

-24.6%

Return on Assets

-16.33%

N/A

Return on Invested Capital

-19.52%

N/A

Free Cash Flow

CN¥25.81M

N/A

Operating Cash Flow

CN¥26.55M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IXHLIncannex Healthcare Limited
$3.08+3.70%
TILInstil Bio, Inc.
$7.30+0.69%
EXOZeXoZymes, Inc.
$5.45+17.97%
ATOSAtossa Therapeutics, Inc.
$2.34+1.30%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$109.67-0.12%
NVDANvidia
$220.94+0.04%
ONDSOndas
$8.90+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.83-0.03%

Questions About ZYBT

What is the current price of Zhengye Biotechnology?

Zhengye Biotechnology is trading at $2.48 per share.

What is the 52-week range for Zhengye Biotechnology?

Over the past 52 weeks, Zhengye Biotechnology has traded between $0.62 and $13.08.

How much debt does Zhengye Biotechnology have?

As of the most recent reporting period, Zhengye Biotechnology reported total debt of CN¥10.74M.

How much cash does Zhengye Biotechnology have on hand?

Zhengye Biotechnology reported CN¥7.20M in cash and cash equivalents in its most recent financial results.

What is Zhengye Biotechnology’s dividend yield?

Zhengye Biotechnology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services